UNICREDIT BANK/CALL/BIOGEN IDEC/300/0.1/18.12.24 Share Price

Warrant

DE000HC3LKJ9

Real-time BOERSE MUENCHEN 08:40:00 29/05/2024 BST
0.51 EUR 0.00% Intraday chart for UNICREDIT BANK/CALL/BIOGEN IDEC/300/0.1/18.12.24
Current month+41.67%
1 month+82.14%
Date Price Change
29/05/24 0.51 0.00%
28/05/24 0.51 -7.27%
27/05/24 0.55 0.00%
24/05/24 0.55 +10.00%
23/05/24 0.5 -1.96%

Real-time BOERSE MUENCHEN

Last update May 29, 2024 at 08:40 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BIOGEN INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC3LKJ
ISINDE000HC3LKJ9
Date issued 27/01/2023
Strike 300 $
Maturity 18/12/2024 (204 Days)
Parity 10 : 1
Emission price 6.72
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 6.77
Lowest since issue 0.13
Delta0.19x
Omega 7.302
Premium39.78x
Gearing38.05x
Moneyness 0.7291
Difference Strike 81.27 $
Difference Strike %+27.09%
Spread 0.16
Spread %26.23%
Theoretical value 0.5400
Implied Volatility 38.00 %
Total Loss Probability 87.43 %
Intrinsic value 0.000000
Present value 0.5400
Break even 305.86 €
Theta-0.03x
Vega0.04x
Rho0.02x

Company Profile

Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (17,2%) ; - other (9,1%): primarily revenues from partnership agreements.
Sector
-
More about the company

Ratings for Biogen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Biogen Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
218.7 USD
Average target price
286.1 USD
Spread / Average Target
+30.78%
Consensus